glp-1 protocol Mapping the effectiveness and risks of receptor agonists The Glp-1 Protocol - by

They help control blood sugar and weight

GLP-1 microdosing is gaining attention as more people look for flexible ways to use GLP-1 medications that better fit their bodies, lifestyles, and long-term health goals

Greenberg NR et al

Many patients are on a combination of an SGLT2 inhibitor with a GLP-1 receptor agonist or tirzepatide (a dual agonist) and have incredible success without adverse reactions, but we are still figuring out the patient characteristics that would put them at higher risk of poor outcomes. Bagley is the senior editor of Endocrine News

Go Straight to the Manufacturer Pharmaceutical companies like Eli Lilly and Novo Nordisk run their own direct pricing programs (LillyDirect for Zepbound and NovoCare for Wegovy) that allow eligible patients to purchase medication directly